Loading
HCA Healthcare, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 28 Mar 2025.
HCA Healthcare, Inc.: what insiders have been doing
Every trade that managers of HCA Healthcare, Inc. disclose to SEC (Form 4) is tracked on this page. The company sits in the Healthcare & Pharma sector and is based in Nashville, United States. It was founded in 1968. 20 insiders have disclosed 33 filings since 18 October 2025.
Only sales appear on the open market, 2 sales in all totalling €6.9M, filed by 2 insiders. Biggest ticket of the year: €6.3M, sold by Hazen Samuel N and made public on 5 February 2026.
The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
Across the 5,458 companies tracked on its exchange, the median is 22 filings; at 33 filings, this issuer sits above that mark. Since 2016, the database holds 5 purchases and 58 sales by insiders of the company. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported revenue of 75.60 bn USD and net income of 6.78 bn USD, with a dividend of 2.88 USD per share.
Other companies in the same sector with recent insider buying flagged by our signals: Anixa Biosciences Inc and Vivos Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
314
Thresholds
n/a
Buy Volume
€1M
5 ops. · all time
Sell Volume
€71M
58 ops. · all time
Who traded when
BuySaleJon M. Foster1 sale
Kathleen M. Whalen1 sale
Michael S. Cuffe1 sale
Samuel N. Hazen1 sale
Since the insiders bought
- +30.3%Entry US$209.78 · Close at T+365 US$273.25
- +24.0%Entry US$224.19 · Close at T+365 US$278.06
- +23.5%Entry US$224.80 · Close at T+365 US$277.63
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate HCA Healthcare, Inc. Buy (bullish), based on 22 analysts. Average price target: US$460.59.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 7,015 of 24,148 companies
62.0
score / 100
Value70
Quality54
FCF yld7.6%
Earn yld6.7%
EV/EBITDA9.6x
ROE·
Gross mgn42%
Net mgn9.0%
Debt/EBITDA3.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$458.84
Analyst consensus
22 analystsBuy
US$380.00Target US$460.59(+0%)US$579.00
Income statement
RevenueUS$75.6B
Gross profitUS$31.4B42% margin
EBITDAUS$15.6B21% margin
Net incomeUS$6.8B8.8% margin
Valuation
PER (trailing)15.4x
PER (forward)14.3x
Beta1.11
Balance sheet & cash
Market capUS$101.8B
Total debtUS$48.7B
Free Cash FlowUS$7.7B
Profitability & ownership
ROA12.3%
% insiders16.6%
% institutions78.8%
Last declaration on 28 August 2026
Declarations314 total
7,769 shares@ US$429.000.0036% mcap42.1% of flowCommon StockSEC:0001193125-26-374693:0
809 shares0Common StockSEC:0001193125-26-197734:0
1,041 shares0Common Stock, par value $0.01 per shareSEC:0001140361-26-018352:0
809 shares0Common Stock, par value $0.01 per shareSEC:0001140361-26-018355:0
809 shares0Common StockSEC:0001193125-26-197757:0
925 shares0Common StockSEC:0001193125-26-197763:0
509 shares0Common StockSEC:0001193125-26-197773:0
509 shares0Common StockSEC:0001193125-26-197746:0
509 shares0Common StockSEC:0001193125-26-197781:0
5,000 shares@ US$236.6114.7% of flowCommon StockSEC:0001193125-26-057701:0
54,934 shares0Common StockSEC:0001193125-26-049200:0
3,350 shares0Common StockSEC:0001193125-26-049224:0
1,676 shares0Common StockSEC:0001193125-26-049221:0
8,372 shares0Common StockSEC:0001193125-26-049217:0
5,026 shares0Common StockSEC:0001193125-26-049208:0
15,696 shares0Common StockSEC:0001193125-26-049197:0
9,628 shares0Common StockSEC:0001193125-26-049186:0
7,116 shares0Common StockSEC:0001193125-26-049184:0
36,629,188 shares0Common Stock, par value $0.01 per shareSEC:0001140361-26-004682:0
36,629,188 sharesCommon Stock, par value $0.01 per shareSEC:0001140361-26-004686:0
36,629,188 sharesCommon Stock, par value $0.01 per shareSEC:0001140361-26-004685:0
36,629,188 sharesCommon Stock, par value $0.01 per shareSEC:0001140361-26-004684:0
36,629,188 sharesCommon Stock, par value $0.01 per shareSEC:0001140361-26-004683:0
36,629,188 sharesCommon Stock, par value $0.01 per shareSEC:0001140361-26-004681:0
29,330 shares@ US$139.0631.6% of flowCommon StockSEC:0001193125-26-043139:0
25 of 314 declarations
About HCA Healthcare, Inc.
HCA Healthcare, Inc. (ticker HCA) is one of the largest for-profit healthcare services groups listed in the United States, and it trades on the NYSE (United States). Headquartered in Nashville, Tennessee, the company was founded in 1968 by Dr. Thomas Frist Sr., Dr. Thomas Frist Jr., and Jack C. Massey. Its original mission was to create a new model for hospital care built on scale, operational discipline, and clinical quality. That founding ethos still shapes HCA Healthcare’s strategy today, making it a long-established benchmark in the U.S. hospital and acute-care market. ([hcahealthcare.com](https://hcahealthcare.com/about/our-history.dot?utm_source=openai))
HCA Healthcare operates an extensive healthcare network that includes hospitals, ambulatory surgery centers, freestanding emergency rooms, urgent care centers, physician clinics, and other outpatient care sites. Its footprint is concentrated primarily in the United States, with an additional presence in the United Kingdom. The company describes itself as a learning health system, using a very large volume of patient encounters to support clinical improvement, research, and operational efficiency. ([investor.hcahealthcare.com](https://investor.hcahealthcare.com/news/news-details/2026/HCA-Healthcare-Named-a-Worlds-Most-Admired-Company-by-Fortune-for-the-12th-Consecutive-Year/default.aspx?utm_source=openai))
Read moreShow less
From a competitive standpoint, HCA’s strengths are its scale, integrated delivery model, broad geographic reach, and ability to expand higher-acuity specialty services alongside outpatient care. The group has also invested in digital and clinical systems intended to improve care coordination and productivity across its network. For investors, this mix matters because it supports a diversified revenue base within a highly fragmented U.S. healthcare landscape, while also giving HCA leverage on purchasing, staffing, and network optimization. ([investor.hcahealthcare.com](https://investor.hcahealthcare.com/news/news-details/2024/HCA-Healthcare-Releases-2024-Annual-Impact-Report/default.aspx?utm_source=openai))
Recent developments underscore the company’s operating momentum and strategic priorities. In first-quarter 2026, HCA reported revenue of $19.109 billion, up 4.3% year over year, net income attributable to HCA of $1.620 billion, and operating cash flow up 22.0%. Management also noted modest growth in admissions and emergency-room visits, while citing seasonal and weather-related pressures on volumes. In 2025, HCA continued to highlight community investment, nursing education support, and healthcare workforce initiatives, reflecting both its social footprint and the labor challenges facing the sector. ([investor.hcahealthcare.com](https://investor.hcahealthcare.com/news/news-details/2026/HCA-Healthcare-Reports-First-Quarter-2026-Results/default.aspx?utm_source=openai))
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
